Human Trials in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Human Trials in Brazil

Human Trials in Brazil – Clinical Trials in Latin America

Brazil is one of the most prominent countries in the world when it comes to conducting human trials, also known as clinical trials.

The country is known for its large population, diverse ethnic groups, well-developed healthcare system, and modern infrastructure for conducting research. Brazil is home to some of the world’s leading medical research institutions, which makes it an attractive location for conducting clinical trials.

One of the main advantages of conducting clinical trials in Brazil is its large and diverse population. With over 210 million people, Brazil is the fifth most populous country in the world. Its population includes a range of ethnic and cultural groups, which can be particularly beneficial for clinical trials as it allows researchers to test how different groups respond to a treatment.

Brazil also has a well-developed healthcare system, with a network of public and private hospitals and clinics that provide a wide range of medical services. These hospitals and clinics have experienced medical staff and modern technology, which makes it easier to conduct clinical trials with a high level of accuracy and precision.

Another advantage of conducting clinical trials in Brazil is its modern infrastructure for conducting research.

The country has established several research centers and institutes that specialize in various medical fields, including oncology, infectious diseases, neurology, and cardiology. Many of these institutions have state-of-the-art equipment and advanced technology for conducting clinical trials, which can be a major advantage for researchers.

Despite these advantages, there have been concerns about the ethical conduct of clinical trials in Brazil. In some cases, vulnerable populations such as the poor, indigenous communities, and prisoners have been exploited or put at risk in clinical trials without their informed consent.

To address these issues, Brazil has implemented a range of regulations and guidelines for the conduct of clinical trials. In 1996, Brazil passed a law that established the National Health Surveillance Agency (ANVISA), which is responsible for overseeing the ethical conduct of clinical trials in the country.

Human Trials in Brazil

Human Trials in Brazil

Human Trials in Brazil

The law also requires that all clinical trials conducted in Brazil be registered with the National Registry of Clinical Trials (RNEC).

One of the key requirements for conducting a clinical trial in Brazil is obtaining informed consent from participants.

This means that participants must be fully informed about the risks and benefits of the treatment, and must voluntarily agree to participate in the trial. In addition, the consent process must be conducted in a language that the participant understands, and the participant must have the option to withdraw from the trial at any time.

Another important regulation in Brazil is the requirement for an independent ethics committee to review and approve all clinical trials. These committees are composed of experts in various fields, including medicine, law, and ethics, and their role is to ensure that the trial is conducted in an ethical and safe manner.

Despite these regulations, there have still been cases of unethical conduct in clinical trials in Brazil. In 2010, for example, a clinical trial for a new cancer treatment was suspended after it was discovered that the participants had not been fully informed about the risks of the treatment.

The incident highlighted the importance of ensuring the safety and ethical conduct of clinical trials.

To address these issues, the Brazilian government has continued to strengthen its oversight and regulation of clinical trials. In 2020, ANVISA issued new guidelines for the conduct of clinical trials, which included stricter requirements for informed consent and greater transparency in reporting trial results.

Overall, while there have been concerns about the ethical conduct of clinical trials in Brazil, the country has made significant strides in improving the regulation and oversight of these trials.

With its large and diverse population, well-developed healthcare system, and modern infrastructure for conducting research, Brazil is likely to continue to be a major location for the development of new medical treatments in the years to come.

Human Trials in Brazil

Source: Duke Clinical Research Institute

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Human Trials in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Human Trials in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Human Trials in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Human Trials in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Human Trials in Brazil

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Human Trials in Brazil

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Human Trials in Brazil

The Cohortias Team

Human Trials in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Human Trials in Brazil

Network & Partnerships